These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15303578)

  • 21. Thrombosis and the antiphospholipid syndrome.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2005; ():462-8. PubMed ID: 16304421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes.
    Scully MF
    J Thromb Haemost; 2005 May; 3(5):840-1. PubMed ID: 15869571
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
    Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
    Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
    Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
    Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How much warfarin is enough in APS related thrombosis?
    Erkan D; Lockshin MD
    Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased PAC-1 expression among patients with multiple myeloma on concurrent thalidomide and warfarin.
    Abdullah WZ; Roshan TM; Hussin A; Zain WS; Abdullah D
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):893-5. PubMed ID: 24030118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombosis in spite of warfarin--what should be done?].
    Lassila R
    Duodecim; 2001; 117(24):2632-6. PubMed ID: 12183826
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiphospholipid antibody syndrome: further evidence to guide clinical practice?
    Crowther MA
    J Rheumatol; 2004 Aug; 31(8):1474-5. PubMed ID: 15290722
    [No Abstract]   [Full Text] [Related]  

  • 32. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
    Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin and the antiphospholipid syndrome: does one size fit all?
    Kasthuri RS; Roubey RA
    Arthritis Rheum; 2007 Dec; 57(8):1346-7. PubMed ID: 18050224
    [No Abstract]   [Full Text] [Related]  

  • 34. The lesser known side-effect of warfarin: warfarin-induced venous limb gangrene.
    Sheng GH; Aronowitz P
    Mayo Clin Proc; 2014 May; 89(5):e47. PubMed ID: 24797650
    [No Abstract]   [Full Text] [Related]  

  • 35. Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha.
    Steurer M; Sudmeier I; Stauder R; Gastl G
    Br J Haematol; 2003 Apr; 121(1):101-3. PubMed ID: 12670338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ear, ear, what's going on in Norfolk?
    Clark E; Gaffney K; Merry P
    Ann Rheum Dis; 1999 Oct; 58(10):660. PubMed ID: 10577378
    [No Abstract]   [Full Text] [Related]  

  • 37. Third occurrence of cerebral venous thrombosis in a 33-year-old woman.
    Amberger N; Weih M; Harms L; Valdueza JM
    Cerebrovasc Dis; 2006; 21(5-6):416-8. PubMed ID: 16549910
    [No Abstract]   [Full Text] [Related]  

  • 38. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
    Perry SL; Samsa GP; Ortel TL
    Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should we screen patients for inherited thrombophilia before starting thalidomide?
    Otrock ZK; Mahfouz RA; El-Hajj II; Harb MI; Sawaya RA
    Am J Clin Oncol; 2006 Feb; 29(1):100-1. PubMed ID: 16462512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis.
    Brunner HI; Chan WS; Ginsberg JS; Feldman BM
    J Rheumatol; 2002 Mar; 29(3):490-501. PubMed ID: 11908562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.